ScienceAlkermes’ orexin agonist reportedly shows potential to treat ADHD in early-stage study
STAT reports that Alkermes said the therapy showed potential to treat people with ADHD for the first time in an early-stage study.
TLDR
Drugmaker Alkermes said an orexin agonist showed potential to treat people with ADHD in an early-stage study, STAT reports. The company described it as the first time the therapy had shown that potential.
Alkermes’ orexin agonist reportedly shows potential to treat ADHD in early-stage study
STAT reports that Alkermes said the therapy showed potential to treat people with ADHD for the first time in an early-stage study.
TLDR
Drugmaker Alkermes said an orexin agonist showed potential to treat people with ADHD in an early-stage study, STAT reports. The company described it as the first time the therapy had shown that potential.